重症成人机械通气镇静临床试验设计:SCEPTER 推荐 III
该共识由镇静终点与操作治疗、教育及研究联盟(SCEPTER)召集 36 名来自学术界、产业界和美国食品药品监督管理局的专家,于 2019 年 3 月 28-29 日在华盛顿特区召开为期 2 天的面对面会议,随后进行三轮在线改良德尔菲共识流程。最终形成 15 条关于研究设计与实施、受试者纳入、结局和测量工具的推荐。共识推荐包括获取 ICU 幸存者和/或其家属的意见、确保人员对 ICU 环境中镇静、疼痛和谵妄评估使用经过验证的工具进行充分培训,以及需要方法学标准化。这些推荐旨在帮助研究者设计、实施、选择终点和报告涉及镇静药物和/或镇静方案的成人 ICU 机械通气患者临床试验,应被视为改进临床试验并减少未来临床试验方法学异质性的起点。
要点
- 共识推荐获取 ICU 幸存者和/或其家属的意见(15 条推荐之一)。
- 共识推荐确保人员对 ICU 环境中镇静、疼痛和谵妄评估使用经过验证的工具进行充分培训。
- 共识强调需要方法学标准化,推荐涉及研究设计与实施、受试者纳入、结局和测量工具四个方面。
- 共识由 36 名多学科专家经面对面会议和三回合改良德尔菲流程形成,最终推荐基于调查结果、参会者反应、小组主持人总结和会议转录审查迭代完善。
- 这些推荐应被视为改进临床试验并减少未来临床试验方法学异质性的起点。
适用人群与场景
- 成人 ICU 需要机械通气的患者(临床试验研究对象)。
- 试验设计者、学术和产业界临床研究者。
研究设计与关键结果
- 制定机构:镇静终点与操作治疗、教育及研究联盟(SCEPTER)。
- 方法:2019 年 3 月 28-29 日在华盛顿特区举行 2 天面对面会议,随后进行三轮在线改良德尔菲共识流程;36 名参与者来自学术界、产业界和美国食品药品监督管理局,包括 2 名既往 ICU 患者,多数完成了在线随访调查并参与改良德尔菲流程。
- 最终推荐基于调查结果、参与者对结果的反馈、小组主持人总结和会议录音转录审查迭代完善,形成 15 条关于研究设计与实施、受试者纳入、结局和测量工具的推荐。
- 共识推荐包括获取 ICU 幸存者和/或其家属的意见、确保人员对 ICU 环境中镇静、疼痛和谵妄评估使用经过验证的工具进行充分培训,以及需要方法学标准化。
证据类型、等级与局限
- 证据类型:共识推荐(改良德尔菲共识流程)。
- 推荐应被视为改进临床试验并减少未来临床试验方法学异质性的起点。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文建议研究者在设计、实施、选择终点和报告涉及镇静药物和/或镇静方案的成人 ICU 机械通气患者临床试验时参考这些推荐。
- 原文推荐获取 ICU 幸存者和/或其家属的意见。
- 原文推荐确保人员对 ICU 环境中镇静、疼痛和谵妄评估使用经过验证的工具进行充分培训。
- 原文强调需要方法学标准化,以减少临床试验异质性。
指南或共识出处
- 指南名称:Design of Clinical Trials Evaluating Sedation in Critically Ill Adults Undergoing Mechanical Ventilation: Recommendations From Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research (SCEPTER) Recommendation III;发布机构:SCEPTER;发表于 Critical Care Medicine。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Clinical trials evaluating the safety and effectiveness of sedative medication use in critically ill adults undergoing mechanical ventilation differ considerably in their methodological approach. This heterogeneity impedes the ability to compare results across studies. The Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research Recommendations convened a meeting of multidisciplinary experts to develop recommendations for key methodologic elements of sedation trials in the ICU to help guide academic and industry clinical investigators.
DESIGN: A 2-day in-person meeting was held in Washington, DC, on March 28-29, 2019, followed by a three-round, online modified Delphi consensus process.
PARTICIPANTS: Thirty-six participants from academia, industry, and the Food and Drug Administration with expertise in relevant content areas, including two former ICU patients attended the in-person meeting, and the majority completed an online follow-up survey and participated in the modified Delphi process.
MEASUREMENTS AND MAIN RESULTS: The final recommendations were iteratively refined based on the survey results, participants' reactions to those results, summaries written by panel moderators, and a review of the meeting transcripts made from audio recordings. Fifteen recommendations were developed for study design and conduct, subject enrollment, outcomes, and measurement instruments. Consensus recommendations included obtaining input from ICU survivors and/or their families, ensuring adequate training for personnel using validated instruments for assessments of sedation, pain, and delirium in the ICU environment, and the need for methodological standardization.
CONCLUSIONS: These recommendations are intended to assist researchers in the design, conduct, selection of endpoints, and reporting of clinical trials involving sedative medications and/or sedation protocols for adult ICU patients who require mechanical ventilation. These recommendations should be viewed as a starting point to improve clinical trials and help reduce methodological heterogeneity in future clinical trials.
参考来源
- Ward DS, Absalom AR, Aitken LM, et al. Design of Clinical Trials Evaluating Sedation in Critically Ill Adults Undergoing Mechanical Ventilation: Recommendations From Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research (SCEPTER) Recommendation III. Crit Care Med. 2021. PMID: 33938718. doi:10.1097/CCM.0000000000005049
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。